Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

FRA:ACT - Deutsche Boerse Ag - DE000A2YNT30 - Common Stock - Currency: EUR

149.2  -1.4 (-0.93%)

Fundamental Rating

7

ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making ACT a very profitable company, without any liquidiy or solvency issues. ACT has a correct valuation and a medium growth rate. With these ratings, ACT could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year ACT was profitable.
In the past year ACT had a positive cash flow from operations.
ACT had positive earnings in each of the past 5 years.
Of the past 5 years ACT 4 years had a positive operating cash flow.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

ACT has a better Return On Assets (11.18%) than 98.53% of its industry peers.
ACT has a better Return On Equity (26.31%) than 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.95%, ACT belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.39%.
The last Return On Invested Capital (14.95%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROIC 14.95%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 9.76%, ACT belongs to the best of the industry, outperforming 80.88% of the companies in the same industry.
ACT's Profit Margin has improved in the last couple of years.
The Operating Margin of ACT (14.16%) is better than 79.41% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
ACT has a better Gross Margin (64.27%) than 95.59% of its industry peers.
ACT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
ACT has a better debt/assets ratio than last year.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ACT has an Altman-Z score of 5.66. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT's Altman-Z score of 5.66 is amongst the best of the industry. ACT outperforms 91.18% of its industry peers.
The Debt to FCF ratio of ACT is 0.85, which is an excellent value as it means it would take ACT, only 0.85 years of fcf income to pay off all of its debts.
ACT has a better Debt to FCF ratio (0.85) than 97.06% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that ACT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.21, ACT is in the better half of the industry, outperforming 69.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Altman-Z 5.66
ROIC/WACC2.14
WACC7%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ACT has a Current Ratio of 2.48. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.48, ACT is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
ACT has a Quick Ratio of 1.52. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
ACT's Quick ratio of 1.52 is fine compared to the rest of the industry. ACT outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.52
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.79%, which is quite impressive.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
ACT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.59%.
ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%

3.2 Future

Based on estimates for the next years, ACT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.19% on average per year.
Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue Next Year3.41%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.83, which means the current valuation is very expensive for ACT.
ACT's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.48. ACT is around the same levels.
With a Price/Forward Earnings ratio of 22.92, ACT is valued on the expensive side.
ACT's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.04. ACT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 26.83
Fwd PE 22.92
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT indicates a somewhat cheap valuation: ACT is cheaper than 61.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.48
EV/EBITDA 14.55
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACT does not grow enough to justify the current Price/Earnings ratio.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 16.33% in the coming years.
PEG (NY)1.87
PEG (5Y)1.09
EPS Next 2Y13.05%
EPS Next 3Y16.33%

4

5. Dividend

5.1 Amount

ACT has a Yearly Dividend Yield of 1.20%.
ACT's Dividend Yield is slightly below the industry average, which is at 3.03.
Compared to an average S&P500 Dividend Yield of 2.39, ACT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

22.58% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.58%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

ALZCHEM GROUP AG

FRA:ACT (8/8/2025, 7:00:00 PM)

149.2

-1.4 (-0.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners40.2%
Ins Owner ChangeN/A
Market Cap1.52B
Analysts81.82
Price Target136.7 (-8.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP22.58%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)14.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE 26.83
Fwd PE 22.92
P/S 2.74
P/FCF 24.48
P/OCF 14.45
P/B 7.39
P/tB 7.52
EV/EBITDA 14.55
EPS(TTM)5.56
EY3.73%
EPS(NY)6.51
Fwd EY4.36%
FCF(TTM)6.09
FCFY4.09%
OCF(TTM)10.33
OCFY6.92%
SpS54.44
BVpS20.19
TBVpS19.83
PEG (NY)1.87
PEG (5Y)1.09
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROCE 20.74%
ROIC 14.95%
ROICexc 17.85%
ROICexgc 18.06%
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
FCFM 11.2%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Debt/EBITDA 0.41
Cap/Depr 163.77%
Cap/Sales 7.78%
Interest Coverage 33.75
Cash Conversion 100.34%
Profit Quality 114.74%
Current Ratio 2.48
Quick Ratio 1.52
Altman-Z 5.66
F-Score7
WACC7%
ROIC/WACC2.14
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%
Revenue Next Year3.41%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%
EBIT growth 1Y36.94%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year48.64%
EBIT Next 3Y26.44%
EBIT Next 5Y19.11%
FCF growth 1Y19.06%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y44.69%
OCF growth 3Y34.7%
OCF growth 5Y19.23%